EDWARD NEUGEBOREN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ELITE PHARMACEUTICALS INC /NV/

Filing Date Source Excerpt
2005-03-08 The members of the Nominating Committee and the Audit Committee are Edward Neugeboren (who succeeded John Moore on January 24, 2005), Harmon Aronson and Eric L. Sichel.
2006-05-25 The members of the Nominating Committee and of the Audit Committee are Edward Neugeboren, Barry Dash and Melvin Van Woert. Each independent director receives $2,000 as compensation for each meeting of the Board of Directors attended.

Data sourced from SEC filings. Last updated: 2026-03-05